I can answer, but “drospirenone clinical trial 120” is too ambiguous on its own to identify the specific study.
What I need to pinpoint the right trial
Please share one of the following so I can locate the exact “Trial 120” and summarize results:
- the drug/product name (e.g., drospirenone + ethinyl estradiol, drospirenone-only, Yaz/Yasmin-related studies)
- the sponsor/company (e.g., Bayer or another manufacturer)
- the clinical trial identifier (e.g., NCT number, EudraCT, or a study code like “Protocol 120”)
- the condition being studied (contraception, acne, endometriosis, PMS/PMDD, etc.)
- where you saw “120” (a paper, a registry page, or a label)
Common ways “trial 120” shows up
In practice, “120” may refer to:
- an internal protocol number (not the public NCT ID),
- a study “phase 3 trial number 120,” or
- a specific study titled “Trial 120” within a larger development program.
Once you provide any identifier (especially an NCT number), I’ll summarize:
- the trial design (phase, randomization, dosing),
- who was enrolled,
- endpoints and key results,
- major safety outcomes (including hyperkalemia-related monitoring where relevant),
- and the citation details.
Reply with the NCT/EudraCT number or the full context you have for “clinical trial 120,” and I’ll take it from there.